Document Detail

Integral laser-photodynamic treatment of multifocal bladder carcinoma photosensitized by hematoporphyrin derivative.
MedLine Citation:
PMID:  2945724     Owner:  NLM     Status:  MEDLINE    
Intravenously administered hematoporphyrin derivative photosensitizes tumorous bladder tissue which can then be destroyed selectively by irradiation with red laser light (630 nm). After experimentally developing a concept since 1978 (light diffusion medium, special bladder catheter) to expose the bladder to the therapeutically effective red laser light, the integral photodynamic therapy is meanwhile performed clinically. The experience gained so far demonstrates that especially the multifocal carcinoma in situ up till now difficult to be detected endoscopically represents a new domain for the integral photodynamic therapy.
D Jocham; E Schmiedt; R Baumgartner; E Unsöld
Related Documents :
25211024 - Associations between diurnal 24-hour rhythm in ambulatory heart rate variability and th...
25406134 - Evaluation of sorghum flour functionality and quality characteristics of gluten-free br...
10582664 - An indwelling brachytherapy balloon catheter: potential use as an intracranial light ap...
25449414 - Feeding behavior and digestive physiology in sea cucumber apostichopus japonicus.
1408644 - Oculomotor readiness and covert orienting: differences between central and peripheral p...
3940044 - The spatial frequency discrimination function at low contrasts.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European urology     Volume:  12 Suppl 1     ISSN:  0302-2838     ISO Abbreviation:  Eur. Urol.     Publication Date:  1986  
Date Detail:
Created Date:  1986-12-09     Completed Date:  1986-12-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  43-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma in Situ / drug therapy,  surgery
Hematoporphyrin Derivative
Hematoporphyrins / therapeutic use*
Laser Therapy*
Radiation-Sensitizing Agents / therapeutic use*
Urinary Bladder Neoplasms / drug therapy,  surgery*
Reg. No./Substance:
0/Hematoporphyrins; 0/Radiation-Sensitizing Agents; 68335-15-9/Hematoporphyrin Derivative

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Return to normal of 99mTc-plasmin test after deep venous thrombosis and its relationship to vessel w...
Next Document:  Integral photoradiation therapy of multifocal bladder tumors.